Treatment of infections in acute leukemias;Therapie von infektionen bei patienten mit akuten leukamien

Medizinische Klinik

Volumn 92, Issue 7, 1997, Pages 406-409

  Hiddemann, Wolfgang ^a   Maschmeyer, Georg ^b   Link, Hartmut ^c   Helmerking, Manfred ^d   Adam, Dieter ^e  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d Studienzentrale Paul Ehrlich G   (Germany)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Anti fungal agents; Antimicrobial chemotherapy; FUO; Pneumonia

Indexed keywords

AMINOGLYCOSIDE; AMINOPENICILLIN; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CARBAPENEM DERIVATIVE; CEPHALOSPORIN DERIVATIVE; GLYCOPEPTIDE;

ACUTE LEUKEMIA; ARTICLE; DRUG EFFICACY; DRUG POTENCY; HUMAN; INFECTION; PNEUMONIA; PROGNOSIS; PYREXIA IDIOPATHICA; TREATMENT FAILURE;

EID: 8544270080     PISSN: 07235003     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03042571     Document Type: Article

References (18)

1. Behre, G., H. Link, G. Maschmeyer, P. Meyer, U. Paaz, M. Wilhelm, W. Hiddemann: Meropenem monotherapy exhibits comparable efficacy to combination therapy with ceftazidime and amikacin for empirical treatment of febrile neutropenic patients. Ann. Hemat. (im Druck).
2. Bodey, G. P: Infection in cancer patienes - a continuing association. Amer. J. Med 81 (1986), 11-26.
3. Brown, A. E.: Neutropenia, fever, and infection. Amer. J. Med. 76 (1984), 421-428.
4. Büchner, T., N. Roos: Antifungal treatment strategy in leukemia patients Ann. Hemat. 65 (1992), 153-161.
5. Büchner, T., W. Hiddemann: Treatment strategies in acute myeloid leukemia - First line chemotherapy (AML). Blut 60, (1990), 61-67.
6. Büchner, T.: Akute myeloische Leukämie. Internist 37 (1996), 1008-1012.
7. Cometta, A., S. Zinner, R. de Bock, T. Calandra, H. Gaya, J. Klastersky, J. Langenaeken, M. Paesmans, C. Viscoh, M. P. Glauser and the International Antimicrobial Therapy Cooperative Group of the European Organisation for the Research and Treatment of Cancer: Piperacillin-Tazobactan plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocatopenic patients with cancer. Antimicrob Agents Chemother. 39 (1995), 445-452.
8. Cometta, A., T. Calandra, H. Gaya, S. H. Zinner, R. de Bock, A. del Fravero, G Bucaneve, F. Crokacrt, W. V. Kern, J. Klastersky, J. Langenaeken, A. Micozzi, A. Padmos, M. Paesmans, C. Viscoli, M. P. Glauser and International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne Dell' Adulto Infection Program: Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. Antimicrob. Agents Chemother. 40 (1996), 1108-1115.
9. Cornely, O. A, W. Hiddemann, H. Link, G. Maschmeyer, B. Glaß, D. Buchheidt, M. Wilhelm, Th. Büchner, Th. Lipp, R. Haas, V. Heinemann, M. Helmerking, D. Adam for the Study Group of the PEG: Interventional antimicrobial therapy in febrile neutropenic patients Paul-Ehrlich-Society for Chemotherapy (PEG) Study II. Ann. Hemat. (im Druck).
10. Freifeld, A. G., T. Walsh, D. Marschall, J. Gress, S. M. Steinberg, J. Hathorn, M. Rubin, P. Jarosinski, V. Gill, R. C. Young, P. A. Pizzo: Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J. clin. Oncol. 13 (1995), 165-176.
11. Gale, R. P., K. A. Foon: Therapy of acute myelogenous leukemia. Semin. Hemat. 24 (1987), 40-54.
12. Hiddemann, W., G. Maschmeyer, V. Runde, H. Einsele: Prophylaxe, Diagnostik und Therapie von Infektionen bei Patienten mit malignen Erkrankungen. Internist 37 (1996), 1212-1224.
13. Hughes, W. T., P. A. Pizzo, J. C. Wade, D. Armstrong, C. D. Webb, L. S. Young: Evaluation of new ann-infective drugs for the treatment of febrile episodes in neutropenic patients. Infectious Diseases Society of America and the Food and Drug Administration. Clin. infect. Dis. 15 (1992), 206-215.
14. Emmunocompromised Host Society Consensus Panel (Pizzo, P. A., D. Armstrong, G. Bodey, B. de Pauw, R. Feld, M. Glauser, H Gaya, J. Karp, J. Klastersky, G. Todeschini, J. Verhoef, J. Wade, L. S. Young, J. Remington): The design, analysis, and reporting of clinical trials on the empirical antibiotic management of the neutropenic patient: report of a consensus panel for the Immunocompromised Host Society. J. infect. Dis. 161 (1990), 397-401.
15. Klastersky, J.: Empiric therapy for febrile granulocytopenic patients: No longer a challenge? Ann. Oncol. 2 (1991), 454-455.
16. Maschmeyer, G., H. Link, P. Meyer, W. Hiddemann, M. Helmerking, E. Eisenmann, J. Schmitt, D. Adam: Empirische antimikrobielle Therapie bei neutropenischen Patienten. Ergebnisse einer multizentrischen Studie der Arbeitsgruppe Infektiologie in der Hämatologie der Paul-Ehrlich-Gesellschaft. Med. Klin 89 (1994), 114-123.
17. Maschmeyer, G., H. Link, W. Hiddemann, P. Meyer, M. Helmerking, E. Eisenmann, J. Schmitt, D. Adam: Pulmonary infiltrations in febrile patients with neutropenia. Risk factors and outcome under empirical antimicrobial therapy in a randomized multicenter study. Cancer 73 (1994), 2296-2304.
18. Pizzo, P. A: Granulocytopenia and cancer therapy. Past problems, current solutions and future challenges. Cancer 65 (1990), 2185-2195.